Publications by authors named "Mohammed Al-Abbadi"
J Cancer Policy
March 2024
Article Synopsis
- Subjective minimizing language in oncology, like terms "safe" and "well-tolerated," can lead to varied interpretations that may undermine patient-centered care and obscure the real risks of treatments.
- A study analyzing abstracts from major oncology conferences found that 15.2% used such language, with Phase 1 trials being the most common, and solid tumors being the primary focus.
- Out of the abstracts using this language, a significant number reported adverse events, yet the subjective terms may downplay the severity and complexity of these risks.
